Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of RxSight Inc (NASDAQ: RXST) closed at $30.97 in the last session, up 1.91% from day before closing price of $30.39. In other words, the price has increased by $1.91 from its previous closing price. On the day, 0.6 million shares were traded. RXST stock price reached its highest trading level at $31.5 during the session, while it also had its lowest trading level at $30.71.
Ratios:
We take a closer look at RXST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.71 and its Current Ratio is at 12.67. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 20, 2024, Downgraded its rating to Hold and sets its target price to $40 from $65 previously.
On December 11, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $56 to $42.
On December 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $52.UBS initiated its Buy rating on December 06, 2024, with a $52 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 16 ’25 when Corley Jesse Anderson bought 1,767 shares for $31.13 per share. The transaction valued at 55,004 led to the insider holds 3,210 shares of the business.
Corley Jesse Anderson bought 1,443 shares of RXST for $45,000 on Jan 15 ’25. The Director now owns 1,443 shares after completing the transaction at $31.18 per share. On Nov 29 ’24, another insider, Goldshleger Ilya, who serves as the insider of the company, sold 3,105 shares for $46.08 each. As a result, the insider received 143,078 and left with 42,246 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 1248230400 and an Enterprise Value of 1022413312. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.73 while its Price-to-Book (P/B) ratio in mrq is 4.50. Its current Enterprise Value per Revenue stands at 7.969 whereas that against EBITDA is -29.236.
Stock Price History:
The Beta on a monthly basis for RXST is 1.18, which has changed by -0.34560722 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $66.54, while it has fallen to a 52-week low of $26.29. The 50-Day Moving Average of the stock is -21.92%, while the 200-Day Moving Average is calculated to be -38.11%.
Shares Statistics:
According to the various share statistics, RXST traded on average about 703.03K shares per day over the past 3-months and 825230 shares per day over the past 10 days. A total of 40.25M shares are outstanding, with a floating share count of 38.27M. Insiders hold about 5.05% of the company’s shares, while institutions hold 84.47% stake in the company. Shares short for RXST as of 1735603200 were 2571911 with a Short Ratio of 3.66, compared to 1732838400 on 2582933. Therefore, it implies a Short% of Shares Outstanding of 2571911 and a Short% of Float of 6.69.
